This important milestone enables Dalton to transfer finished cGMP cannabis products to licensed dealers.

TORONTO (PRWEB)
January 15, 2020

Dalton Pharma Services (“Dalton”), a Health Canada licensed, FDA inspected global leader in the development and manufacture of innovative pharmaceutical products, is pleased to announce that it has received a three-year renewal and license amendment from Health Canada under the Cannabis Regulations. This amendment authorizes Dalton to sell cGMP cannabis derived products on a “business-to-business” basis to Federal License holders.

With our combined Health Canada cGMP and Cannabis licenses, Dalton is uniquely positioned to test, develop, produce, and supply cGMP cannabinoids to support the delivery and commercial success of our clients’ medical cannabinoid products. It’s a privilege to be part of this exciting movement which will provide patients worldwide access to cannabis derived pharmaceutical products, including high-purity cannabidiol formulations made to the highest cGMP standards in the industry.

“This important milestone enables Dalton to transfer finished cGMP cannabis products to licensed dealers. Dalton’s Health Canada licensed cGMP pharmaceutical manufacturing facility is now supporting the imminent commercial launch of CardiolRx™, a high concentration pharmaceutically-produced cannabidiol formulation developed through our exclusive partnership with Cardiol Therapeutics, and providing innovative pharmaceutical cannabis products and services to the medical cannabis industry. Dalton is excited to be able to support the industry-wide need for cGMP compliant cannabis manufacturing capabilities to supply our clients’ products to patients,” said Peter Pekos, CEO of Dalton Pharma.

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (TSX: CRDL; OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (CBD) products and developing innovative therapies for heart disease, including acute myocarditis and other causes of heart failure. The Company’s lead product, CardiolRx™, is designed to be one of the safest and most consistent cannabidiol formulations on the market. CardiolRx is pharmaceutically produced, manufactured under cGMP, and is THC free (less than 10 ppm). The Company plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is also pursuing distribution opportunities in Europe and Latin America.

In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age.

The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical cannabidiol and other anti-inflammatory drugs directly to sites of inflammation in the heart that are associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated healthcare costs in the U.S. alone exceeding $30 billion. For further information about Cardiol Therapeutics, please visit http://www.cardiolrx.com.

About Dalton Pharma Services:

Dalton Pharma Services is a leading North American cGMP pharmaceutical manufacturing organization providing integrated drug discovery, development, and manufacturing services. We are FDA inspected and Health Canada approved bringing over 30 years of experience to every project. Focusing on developing innovative medicines and backed by the latest technologies, Dalton is committed to bringing breakthrough medical products to the global cannabis market. Our integrated services (drug discovery, formulation and process development, custom synthesis,

cGMP sterile fill/finish of liquids and powders, cGMP API manufacturing and/or dosage form manufacturing and Accelerated Stability Testing) all at one location enhance our ability to support our clients pharmaceutical development programs efficiently and cost effectively.

To learn more about our history and capabilities, please visit http://www.dalton.com.

Peter Pekos

CEO

Dalton Pharma Services

349 Wildcat Road

Toronto, Ontario

Tel: 416-661-2102

Share article on social media or email:

Longeviti InvisiShunt & ClearFit

BALTIMORE (PRWEB)
January 15, 2020

Engineered Medical Systems, Longeviti Neuro Solutions and The LaunchPort™ announced today that they have entered into an agreement to place new, low temperature, low toxicity hydrogen peroxide sterilization capacity at The LaunchPort™/EMS facility in Port Covington. The systems are being procured by Longeviti to support the Maryland production of their Low-profile Intracranial Devices (L.I.D.) platform. The Longeviti L.I.D. Platform has led to several innovative FDA cleared products thus far, the ClearFit and InvisiShunt, and more are in development. The systems will be operated by Engineered Medical Systems within EMS’s regulated medical manufacturing facility at LaunchPort™. These new systems are expected to have completed initial validations by the end of Q1 2020.

At the same time, Longeviti will become an addition to the LaunchPort™ Resident family and will open a development office within LaunchPort’s expanded medical device engineering area. That move-in is also slated to be completed in the 1Q of 2020.

Beyond Longeviti’s requirements, the excess sterilization capacity will be used to support the needs of LaunchPort’s current and future medical device residents, as well as other regional corporate and institutional developers along the I-95 corridor. Parties interested in exploring the use of this new capacity should contact Robert Storey, LaunchPort Managing Partner, at bstorey@mvrco.com.

About Longeviti Neuro Solutions (Hunt Valley, MD)

Longeviti is a neurotechnology company with a focus on surgical solutions for complex brain surgeries. The company manufactures and distributes neurosurgical implants globally with headquarters located in Hunt Valley, MD. Longeviti was founded in 2016 by a team of leading medical device industry executives, neurosurgeons, and biomedical engineers. Longeviti’s areas of expertise and continued focus include functional neurosurgery, neuro reconstruction, neuromodulation, and neuroplastic surgery.

About Engineered Medical Systems (Indianapolis, IN; Baltimore, MD; Penang, Malaysia)

Established in 1986, Engineered Medical Systems, does contract manufacturing and private label medical devices for a variety of private and multi-national medical devices manufacturers and distributors. Engineered Medical Systems – Malaysia in Penang, Malaysia was established in 2014 to support international products and markets. All EMS facilities are ISO-13485 certified facilities.

A sister company of EMS, Pulmodyne, Inc., develops, markets and sells a proprietary line of products in the Critical Care, Airway Management and Emergency markets, with a worldwide sales network of over 70 global distributors and 15 domestic distributors.

About The LaunchPort™ (Port Covington, Baltimore, MD)

The LaunchPort™ is a manufacturing accelerator that allows Medtech start-ups and emerging technology developers the ability to co-locate at an experienced, regulated manufacturing center. Located at the “City Garage” in Baltimore’s Port Covington, it is in close proximity to two of the Country’s premier medical schools (Johns Hopkins and University of Maryland) and at the center of the Nation’s largest urban investment project.

Share article on social media or email:

Modern Living with kathy ireland® with ConTIPI Medical

Modern Living with kathy ireland® is pleased to announce an exclusive interview with ConTIPI Medical CEO Dr. Elan Ziv to discuss their revolutionary new device for pelvic organ prolapse.

LOS ANGELES (PRWEB)
January 14, 2020

Modern Living with kathy ireland® is pleased to announce an exclusive interview with ConTIPI Medical CEO Dr. Elan Ziv to discuss their revolutionary new device for pelvic organ prolapse.

ConTIPI Medical is a company that develops non-surgical and disposable vaginal solutions for women with various pelvic floor disorders. ConTIPI Medical is spearheaded by a strong management team with extensive experience and proven ability to bring a product from concept to market, and is backed by well-known consultants in Israel and abroad. As a dedicated research and development company, the entire development of its products is conducted within the company. Each device made by ConTIPI Medical comes ready for use within a wrapper for women to use in the comfort of their own home. The devices for pelvic floor disorders are inserted vaginally in small dimensions inside an applicator.

Dr. Ziv says that pelvic floor disorders affect hundreds of millions of women worldwide, and new devices from the ConTIPI Medical team are making big strides in the field. He explains, “Pelvic floor disorders are a big set of disorders that affect about fifty percent of women of all ages around the world. Two of these disorders are very prevalent. Urinary incontinence affects about thirty-five to forty percent of women worldwide, and pelvic organ prolapse affects about fifty percent of women. There are many other dysfunctions as well. All of our devices follow the same concept. They’re very small and they go into the vagina within an applicator. These devices join other devices in other parts of medicine, which aim at moving management of some medical conditions into the homes of the patients. This is a global trend and we are proud of bringing such breakthrough solutions into the pelvic floor arena, thereby empowering women.”

For more information about ConTIPI Medical, visit ConTIPI.com and tune in to WE tv as sponsored content on Thursday, January 16, 2020 at 7:30am EST.

About Modern Living with kathy ireland®

Modern Living with kathy ireland® is an independently produced television series airing domestically on WE tv as sponsored content and on Bloomberg Internationally. Hosted by lifestyle influencer and business mogul Kathy Ireland, the series features the latest in lifestyle and B2C trends, breakthroughs, and solutions, while highlighting companies from around the globe in a unique and credible format. For more about Modern Living with kathy ireland®, visit modernlivingtv.com and check out the series on social media!

Share article on social media or email:

Since the addition of Cypress Benefit Administrators, Lucent has experienced tremendous growth of our platform and capabilities as a data-driven, self-funding solution for employers.

APPLETON, Wis. (PRWEB)
January 14, 2020

Lucent Health is pleased to announce the completion of Cypress Benefit Administrators’ (Cypress) transition to the Lucent Health brand effective January 1, 2020.

Founded in 2014, Lucent’s focus has been to provide data-driven solutions and cost containment programs for employers. With offices across the country, Lucent serves employers and members nationwide, offering self-funded health plans that reduce costs while improving the member experience.

Lucent Health’s goal in acquiring Cypress Benefit Administrators in 2017 was to expand its mission and vision of managing cost control strategies, proactively using health plan data to help employers predict trends, minimizing risk and making better, more informed decisions. Lucent has 400 employees to serve more than 800 clients and 250,000 members in a variety of industries and group sizes.

“Since the addition of Cypress Benefit Administrators, Lucent has experienced tremendous growth of our platform and capabilities as a data-driven, self-funding solution for employers. Working with Tom Doney and Marsha Phillips, the founders of Cypress, has been key in our success,” said Brett Rodewald, Lucent Health’s president and CEO.

Cypress opened its doors in 2000 with a focus on forward-thinking cost containment solutions and experienced great success with its efforts. The TPA consistently kept plan cost increases below the national trend, coming in at less than 1% the last two years. Cypress’s average increase from 2012 to 2018 was just 1.24% compared to 6.27% for plans nationally.

“Operating with such similar goals and high standards in serving employers and employees through self-funding, the partnership between Cypress and Lucent was a natural fit from the very beginning,” said Tom Doney, Cypress’s president. “We chose to make a gradual transition as the Cypress name and positive reputation have both become so well-known in the industry.”

About Lucent Health

Lucent Health (@LucentHealth), based in Nashville, TN, empowers U.S. employers with personalized member care, vital healthcare plan performance data and reduces healthcare risks and costs while improving employee access to innovative services. Lucent offers a wide range of innovative data-driven and member-centric products including Lucent Traditional self-funding, Lucent Clarity™ value-based payments, e2 MEC/MV™ solutions, Lucent Vista™ level funded, Lucent Tribia™ a tribal enterprise health plan and Lucent Surity™ for captives. The Lucent Health family of companies consists of Capitol Administrators, Cypress Benefit Administrators and North America Administrators.

Share article on social media or email:

SignatureCare Emergency Center, Houston Westchase District

Immunizations are designed to prevent families from spreading the flu virus but it only works if they receive their flu shots. If they fail to get their flu shots, they leave themselves and everyone around them vulnerable to the flu virus. It is essential that families get immunized.

HOUSTON (PRWEB)
January 14, 2020

Physicians with SignatureCare Emergency Centers throughout Texas are reporting a surge in the number of patients coming into the emergency room with flu symptoms.

According to the ER physicians, the number of flu patients coming into the ER spiked during the holidays compared to the previous month.

“We expected an increase due to the seasonal cold weather but I don’t think anyone expected this many patients coming in with the flu. One reason could be that some Texans may not have received their annual immunizations,” said Dr. Hashibul Hannan, a board-certified emergency room physician and managing partner at SignatureCare Emergency Center.

Dr. Hannan urged Texas families who have not received their immunizations to consider doing so as soon as possible.

“Immunizations are designed to prevent families from spreading the flu virus but it only works if they receive their flu shots. If they fail to get their flu shots, they leave themselves and everyone around them vulnerable to the flu virus. It is essential that families get immunized,” he said.

Dr. Hannan added that “the influenza virus can be especially dangerous for children, the elderly and those with compromised immune system due to other illnesses. These individuals are especially susceptible to the flu virus and could be at greater risk of complications from the flu, so it is important that they are up to date on their flu shots”.

Various medical clinics and urgent care centers administer free or low-cost flu shots throughout Texas.

“Our goal at SignatureCare is to keep Texas families healthy. We care about our neighbors and we are always looking for ways to help the community stay healthy. That is why we are sounding this alarm to let our fellow Texans know that it may be time to get immunized, if they have not done so already,” Dr. Hannan said.

The Texas Department of State Health Services said in its Current Extended Flu Activity Report released January 10, 2020, that flu activity in the state jumped during the last week of December 2019.

Also, the Centers for Disease Control and Prevention (CDC) confirmed that the number of flu patients visiting emergency rooms throughout the nation was higher than normal during the holidays in several states.

According to the CDC, several states, including Texas, saw higher flu activities during the month of December, 2019. An Influenza Surveillance Report prepared by the Influenza Division of the CDC said Influenza-Like Illness (ILI) activity level was widespread in 45 states including Texas, and Puerto Rico, while other states saw low to moderate flu activities.

The CDC has also released a short video showing steps families can take to protect against the influenza virus.

About SignatureCare Emergency Center

Houston, TX based SignatureCare Emergency Center owns 24-hour emergency centers throughout Texas including nine locations in the Houston area (Montrose, Houston Heights, Cypress/FM 1960, Copperfield, Memorial City, Westchase, Bellaire, Mission Bend/Sugar Land and Stafford), Killeen, Austin, College Station, Paris, Midland, Odessa and Texarkana, TX.

Additional information is on our website at https://ercare24.com.

Share article on social media or email:

CHEM+POUR Bag

The Simple Lifecycle products will allow our partners, existing and new, to simply get what they need quickly to best fulfill their needs and meet their timelines.

FORT WORTH, Texas (PRWEB)
January 14, 2020

Lifecycle Biotechnologies announces the new line of chemicals and reagents filled in their 1L and 4L CHEM+POUR Bags, which were designed to provide an evolved experience as compared to bottles and to support aseptic Manufacturing. All specifications have been aligned with what the life science industry is accustomed to purchasing, to provide a simple plug and play solution. The new Simple Lifecycle line of ready to use chemicals and reagents includes:

• 
  Water, Sterile Filtered – Meets Specifications for USP Sterile Water for Irrigation
• 0.9% Sodium Chloride – Meets Specifications for USP Sterile Saline for Irrigation
• 10X Tris Buffered Saline
• 10X Sodium Phosphate Buffer
• USP Purified Water
• 0.1N Hydrochloric Acid
• USP 71 Sterility Tested, Sodium Azide 5% w/v
• 10% Dimethyl Sulfoxide (DMSO)
• 20% Ethanol
• 0.1M Sodium Hydroxide

“Fact is supply chains are complicated. The demands of running a business doesn‘t allow for a slow process to get what you need. When you have a need you need an immediate solution. This is where our new line of Simple Lifecycle products come in,” said Aaron Schieving, Vice President, Sales and Marketing for Lifecycle Biotechnologies. “It will allow our partners, existing and new, to simply get what they need quickly to best fulfill their needs and meet their timelines.”

With the Simple Lifecycle line of products also comes the benefit of an 84% reduction in waste that the CHEM+POUR bags provide, as compared to bottles. Other than using the CHEM+POUR Bags, there is no other action necessary to gain this reduction in waste. To enhance the sustainability and reduce waste even further, these products would also be eligible for their Sustainable Lifecycle Recycling Program. As a medical grade plastic manufacturer, Lifecycle is committed to making a difference; their commitment starts with a recycling program unlike any other life science supplier for their packaging. The CHEM+POUR Bags are eligible for their Sustainable Lifecycle Recycling Program and as part of this program Lifecycle will collect the packaging waste once empty, to clean, cut, regrind, and repursue into new plastic products. This program ensures this packaging waste is kept out of the landfill or the oceans and will help break the negative impact associated with the industry’s plastic addiction.

“The fact that we can simultaneously simplify your supply chain and build sustainability in your process with these new Simple Lifecycle products is a big deal. We are excited about it as it truly allows us and our partners to make a difference.” said Schieving. “You start by doing something different, even if it feels like it’s really small and really pointless as even small actions like that can have a ripple effect that lead to a much greater impact. Will you help us make a difference?”

Lifecycle also offers septum caps, spike adapters, luer to spike connectors, as well as other supplementary components to support a multitude of applications in addition to pouring for the Simple Lifecycle products.

To learn more about Lifecycle Biotechnologies, the industries it serves, or to get a quick quote on any of these products to use to compile your order so we will get these reagents in your hands ASAP, please contact Lifecycle Biotechnologies at info@lifecyclebio.com, 817.840.7855, or http://www.lifecyclebio.com. You can also find more information in the 2020 Lifecycle Prospectus.

Based in Ft. Worth, TX, Lifecycle Biotechnologies has served the life science industry for over 40 years. Lifecycle’s products are the beginning of the lifecycle of the lifesaving and life-enhancing medical products used globally today. As a leading life sciences tools and service supplier, Lifecycle fully understands the critical role its products play in many of the world’s leading pharmaceuticals, medical devices, biologics, diagnostics, cellular agriculture, cell- and tissue-based products, and many other medical products. While Lifecycle’s products aren’t used to diagnose, treat, or cure patients, without their contribution, none of this would be possible.

Share article on social media or email: